| Product Code: ETC9960584 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Bacteriophages Therapy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Bacteriophages Therapy Market - Industry Life Cycle |
3.4 United States (US) Bacteriophages Therapy Market - Porter's Five Forces |
3.5 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections, driving the need for alternative therapies like bacteriophages. |
4.2.2 Growing awareness and acceptance of bacteriophage therapy among healthcare professionals and patients. |
4.2.3 Rising investments in research and development of bacteriophage-based treatments. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and uncertainties surrounding the approval and commercialization of bacteriophage therapies. |
4.3.2 Limited clinical data and standardized protocols for bacteriophage therapy, hindering widespread adoption. |
4.3.3 Competition from established antibiotics and other antimicrobial therapies. |
5 United States (US) Bacteriophages Therapy Market Trends |
6 United States (US) Bacteriophages Therapy Market, By Types |
6.1 United States (US) Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 United States (US) Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 United States (US) Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 United States (US) Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United States (US) Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 United States (US) Bacteriophages Therapy Market Export to Major Countries |
7.2 United States (US) Bacteriophages Therapy Market Imports from Major Countries |
8 United States (US) Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials evaluating bacteriophage therapies in the US. |
8.2 Adoption rate of bacteriophage therapy in US hospitals and healthcare facilities. |
8.3 Investment trends in the US bacteriophage therapy market. |
8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for bacteriophage therapy development. |
9 United States (US) Bacteriophages Therapy Market - Opportunity Assessment |
9.1 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Bacteriophages Therapy Market - Competitive Landscape |
10.1 United States (US) Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here